Evidence map›Paper›PMID 39505342›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2024

[A deep learning model based on magnetic resonance imaging and clinical feature fusion for predicting preoperative cytokeratin 19 status in hepatocellular carcinoma].

W Fang, H Xiao, S Wang, X Lin, C Chen

Abstract readEnglish Abstract
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

W FangSchool of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.
H XiaoSchool of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.
S WangGuangdong Shunde Innovative Design Institute, Foshan 528300, China.
X LinGuangdong Shunde Innovative Design Institute, Foshan 528300, China.
C ChenSchool of Biomedical Engineering, Southern Medical University, Guangzhou 510515, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo establish a deep learning model for testing the feasibility of combining magnetic resonance imaging (MRI) deep learning features with clinical features for preoperative prediction of cytokeratin 19 (CK19) status of hepatocellular carcinoma (HCC).

methodsA retrospective experiment was conducted based on the data of 116 HCC patients with confirmed CK19 status. A single sequence multi-scale feature fusion deep learning model (MSFF-IResnet) and a multi-scale and multimodality feature fusion model (MMFF-IResnet) were established based on the hepatobiliary phase (HBP), diffusion weighted imaging (DWI) sequences of enhanced MRI images, and the clinical features significantly correlated with CK19 status. The classification performance of the models were evaluated to assess the effectiveness of the deep learning models for predicting CK19 status of HCC before surgery.

resultsMultivariate analysis showed that an increased neutrophil-to-lymphocyte ratio (

conclusionThe multi-scale and multi-modality feature fusion model based on MRI and clinical parameters is capable of predicting CK19 status of HCC, demonstrating the feasibility of combining deep learning methods with MRI and clinical features for preoperative prediction of CK19 status.

Indexed as

Carcinoma, HepatocellularDeep LearningKeratin-19Liver NeoplasmsMagnetic Resonance ImagingFemaleHumansMaleMiddle AgedRetrospective StudiesKeratin-19cytokeratin 19deep learningmagnetic resonance imagingmulti-modality datamulti-scale feature fusion

Identifiers

PMID39505342
PMCPMC11744095

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.